Abstract
BACKGROUND: The emergence of carbapenem-resistant Enterobacteriaceae (CRE) is a threat to public health worldwide. This study aimed to determine the risk factors and outcomes for CRE colonization and infection in infants.
METHODS: Children aged <1 year hospitalized with CRE pathogens isolated from January 2016 to June 2019 were retrospectively analyzed. Demographic and clinical data were examined.
RESULTS: A total of 48 infections were identified in 70 infants aged <1 year, and 66.7% (32/48) of these infants were born preterm. The infection rate in infants aged <1 month was higher than that of others (P = 0.005). The most commonly isolated CRE was Klebsiella pneumoniae (60.4%, 29/48), followed by Enterobacter cloacae complex (18.8%, 9/48). Sputum (37.5%, 18/48), blood (27.1%, 13/48), and urine (25.0%, 12/48) were the most common clinical samples. Urinary tract infection was common in infants aged 6-12 months. CRE infection was associated with mechanical ventilation (P = 0.037), central venous catheter (CVC) insertion (P = 0.034), and congenital heart disease (P = 0.027). The hospital stay of patients with CRE infection was longer (median, 75 days; SD, 66.4 days), and their all-cause mortality (6.4%) was higher than those with colonization.
CONCLUSIONS: CRE infection was common in infants aged <1 month, and patients usually had longer hospitalization. Carbapenemase production was not common. Mechanical ventilation, CVC insertion, and congenital heart disease were associated with a higher risk of CRE acquisition in infants aged <1 year.
Original language | English |
---|---|
Pages (from-to) | 168-175 |
Number of pages | 8 |
Journal | Pediatrics and Neonatology |
Volume | 64 |
Issue number | 2 |
DOIs | |
State | Published - 03 2023 |
Bibliographical note
Copyright © 2022 Taiwan Pediatric Association. Published by Elsevier B.V. All rights reserved.Keywords
- carbapenem-resistant Enterobacteriaceae
- children
- colonization
- infection
- Carbapenems/therapeutic use
- Humans
- Risk Factors
- Infant
- Carbapenem-Resistant Enterobacteriaceae
- Enterobacteriaceae Infections/drug therapy
- Retrospective Studies
- Child
- Anti-Bacterial Agents/therapeutic use
- Infant, Newborn